$1.87 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 100 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPRX | ROYALTY PHARMA PLC | $93,666,286 | -14.7% | 3,047,049 | 0.0% | 5.01% | +8.0% | |
| ITCI | INTRA-CELLULAR THERAPIES INC | $75,918,844 | +16.9% | 1,198,971 | 0.0% | 4.06% | +48.0% | |
| PROKIDNEY CORP | $35,731,628 | -1.1% | 3,193,175 | 0.0% | 1.91% | +25.1% | ||
| AGIO | AGIOS PHARMACEUTICALS INC | $12,857,280 | +23.3% | 454,000 | 0.0% | 0.69% | +55.8% | |
| SANA | SANA BIOTECHNOLOGY INC | $12,598,248 | +82.3% | 2,113,800 | 0.0% | 0.67% | +130.8% | |
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $9,721,058 | +86.7% | 7,364,438 | 0.0% | 0.52% | +136.4% | |
| ALVOTECHordinary shares | $7,740,000 | -40.0% | 1,000,000 | 0.0% | 0.41% | -24.0% | ||
| BNTX | BIONTECH SEsponsored ads | $4,421,892 | -13.4% | 40,970 | 0.0% | 0.24% | +9.3% | |
| ELAN | ELANCO ANIMAL HEALTH INC | $4,395,214 | +7.0% | 436,900 | 0.0% | 0.24% | +35.8% | |
| AKILI INC | $4,264,307 | -30.6% | 3,841,718 | 0.0% | 0.23% | -12.3% | ||
| BNTC | BENITEC BIOPHARMA INC | $3,117,911 | +1831.6% | 769,000 | 0.0% | 0.17% | +2285.7% | |
| AZN | ASTRAZENECA PLCsponsored adr | $2,568,647 | +3.1% | 35,890 | 0.0% | 0.14% | +30.5% | |
| NTRA | NATERA INC | $2,525,454 | -12.4% | 51,900 | 0.0% | 0.14% | +10.7% | |
| MOLN | MOLECULAR PARTNERS AGads | $2,488,000 | +3.0% | 400,000 | 0.0% | 0.13% | +30.4% | |
| INCY | INCYTE CORP | $2,340,600 | -13.9% | 37,600 | 0.0% | 0.12% | +8.7% | |
| ABT | ABBOTT LABS | $2,247,992 | +7.7% | 20,620 | 0.0% | 0.12% | +36.4% | |
| GLPG | GALAPAGOS NVspon adr | $1,919,152 | +5.2% | 47,200 | 0.0% | 0.10% | +33.8% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $1,828,982 | +55.3% | 4,059,894 | 0.0% | 0.10% | +96.0% | |
| GILD | GILEAD SCIENCES INC | $1,749,489 | -7.1% | 22,700 | 0.0% | 0.09% | +17.5% | |
| ILMN | ILLUMINA INC | $1,636,788 | -19.4% | 8,730 | 0.0% | 0.09% | +2.3% | |
| IQV | IQVIA HLDGS INC | $1,612,725 | +13.0% | 7,175 | 0.0% | 0.09% | +43.3% | |
| MDT | MEDTRONIC PLC | $1,538,226 | +9.3% | 17,460 | 0.0% | 0.08% | +39.0% | |
| ARGX | ARGENX SEsponsored adr | $1,321,185 | +4.6% | 3,390 | 0.0% | 0.07% | +34.0% | |
| CVS | CVS HEALTH CORP | $1,186,962 | -7.0% | 17,170 | 0.0% | 0.06% | +16.7% | |
| CI | THE CIGNA GROUP | $1,122,400 | +9.8% | 4,000 | 0.0% | 0.06% | +39.5% | |
| BSX | BOSTON SCIENTIFIC CORP | $986,656 | +8.1% | 18,241 | 0.0% | 0.05% | +35.9% | |
| WAT | WATERS CORP | $839,601 | -13.9% | 3,150 | 0.0% | 0.04% | +9.8% | |
| MCK | MCKESSON CORP | $781,977 | +20.0% | 1,830 | 0.0% | 0.04% | +50.0% | |
| DXCM | DEXCOM INC | $755,639 | +10.6% | 5,880 | 0.0% | 0.04% | +37.9% | |
| A | AGILENT TECHNOLOGIES INC | $600,048 | -13.1% | 4,990 | 0.0% | 0.03% | +10.3% | |
| IDXX | IDEXX LABS INC | $462,052 | +0.4% | 920 | 0.0% | 0.02% | +31.6% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $300,220 | -1.4% | 1,360 | 0.0% | 0.02% | +23.1% | |
| MTD | METTLER TOLEDO INTERNATIONAL | $215,109 | -14.3% | 164 | 0.0% | 0.01% | +9.1% | |
| CRL | CHARLES RIV LABS INTL INC | $212,353 | +4.2% | 1,010 | 0.0% | 0.01% | +22.2% | |
| OPY ACQUISITION CORP I*w exp 09/22/202 | $10,891 | 0.0% | 72,605 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.